Join us on Thursday, 25 July 2024 from 7:00 pm to 8:00 pm (AEST) as we discuss the following in relation to the benefits of SGLT2 inhibitors in diabetes management:

• Role of glycaemic control
• Impact of glucose lowering on renal and cardiac function
• Where SGLT2i fit in and change the paradigm
• Navigating the new PBAC recommendations on SGLT2i and GLP-1a

Speakers

Click here to view the event flyer.
Click here to register for the webinar.

For any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au